Impax Reports Fourth Quarter and Full Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street dips as higher yields, rising oil prices mark shaky start to SeptemberÂ
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Impax Laboratories (IPXL) PT Lowered to $10 at RBC Capital
March 2, 2017 6:19 AM ESTRBC Capital lowered its price target on Impax Laboratories (NASDAQ: IPXL) to $10.00 (from $15.00) while maintaining a Sector Perform rating following results
Analyst Randall Stanicky commented, "The stock was down -35% following IPXL's 4Q results and first-time 2017 update (no revenue or EPS... More
Piper Jaffray Downgrades Impax Laboratories (IPXL) to Underweight
March 1, 2017 2:50 PM ESTPiper Jaffray downgraded Impax Laboratories (NASDAQ: IPXL) from Neutral to Underweight with a price target of $7.00.
For an analyst ratings summary and ratings history on Impax Laboratories click here. For more ratings news on Impax Laboratories click here.
Shares of Impax Laboratories closed at $14.25 yesterday.
... MoreImpax Laboratories (IPXL) Reports In-Line Q4 EPS
March 1, 2017 6:36 AM ESTImpax Laboratories (NASDAQ: IPXL) reported Q4 EPS of $0.16, in-line with the analyst estimate of $0.16. Revenue for the quarter came in at $198.4 million versus the consensus estimate of $219.25 million.
For earnings history and earnings-related data on Impax Laboratories (IPXL) click here.
... More